The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism
Open accessAbstract
Global metabolic profiling currently achievable by untargeted mass spectrometry‐based metabolomic platforms has great potential to advance our understanding of human disease states, including potential utility in the detection of novel and known inborn errors of metabolism (IEMs). There are few studies of the technical reproducibility, data analysis methods, and overall diagnostic capabilities when this technology is applied to clinical specimens for the diagnosis of IEMs. We explored the clinical utility of a metabolomic workflow capable of routinely generating semi‐quantitative z‐score values for ~900 unique compounds, including ~500 named human analytes, in a single analysis of human plasma. We tested the technical reproducibility of this platform and applied it to the retrospective diagnosis of 190 individual plasma samples, 120 of which were collected from patients with a confirmed IEM. Our results demonstrate high intra‐assay precision and linear detection for the majority compounds tested. Individual metabolomic profiles provided excellent sensitivity and specificity for the detection of a wide range of metabolic disorders and identified novel biomarkers for some diseases. With this platform, it is possible to use one test to screen for dozens of IEMs that might otherwise require ordering multiple unique biochemical tests. However, this test may yield false negative results for certain disorders that would be detected by a more well‐established quantitative test and in its current state should be considered a supplementary test. Our findings describe a novel approach to metabolomic analysis of clinical specimens and demonstrate the clinical utility of this technology for prospective screening of IEMs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438
Cited by
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Metabolomics toward personalized medicine
Jacob, M., Lopata, A. L., Dasouki, M., & Abdel Rahman, A. M. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21548 · Cited by 400
Roth, K., Yang, Z., Agarwal, M., Liu, W., Peng, Z., Long, Z., Birbeck, J., Westrick, J., Liu, W., & Petriello, M. C. (2021) · Environment International · doi:10.1016/j.envint.2021.106843 · Cited by 307
Promises and pitfalls of untargeted metabolomics
Gertsman, I., & Barshop, B. A. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0130-7 · Cited by 271
Disease progression in women with X-linked adrenoleukodystrophy is slow
Huffnagel, I. C., Dijkgraaf, M. G. W., Janssens, G. E., van Weeghel, M., van Geel, B. M., Poll-The, B. T., Kemp, S., & Engelen, M. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1008-6 · Cited by 100
Metadata
- Authors
- Miller, M. J., Kennedy, A. D., Eckhart, A. D., Burrage, L. C., Wulff, J. E., Miller, L. A. D., Milburn, M. V., Ryals, J. A., Beaudet, A. L., Sun, Q., Sutton, V. R., & Elsea, S. H.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2015-04-15
- Volume
- 38
- Issue
- 6
- Pages
- 1029-1039
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W1985051677
- Cited by
- 212
- References
- 1
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism. https://app.cochat.ai/papers/10.1007/s10545-015-9843-7
- The paper
- Miller, M. J., Kennedy, A. D., Eckhart, A. D., Burrage, L. C., Wulff, J. E., Miller, L. A. D., Milburn, M. V., Ryals, J. A., Beaudet, A. L., Sun, Q., Sutton, V. R., & Elsea, S. H. (2015). Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-015-9843-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.